Cervical Cerclage for Preventing Spontaneous Preterm Birth in Singleton Pregnancies Without Prior Spontaneous Preterm Birth and With Short Transvaginal Ultrasound Cervical Length
1 other identifier
interventional
587
1 country
1
Brief Summary
Spontaneous preterm birth (SPTB) remains the number one cause of perinatal mortality in many countries, including the United States. In singleton gestations a short cervical length (CL) on transvaginal ultrasound (TVU) has been shown to be a good predictor of SPTB. Different strategies have been adopted for prevention of SPTB. Growing interest has focused on pessary for prevention of SPTB. Cervical pessary is relatively non-invasive, easy to use, does not require anesthesia, can be used in an outpatient clinic setting, and it is easily removed when necessary. However, a recent systematic review and meta-analysis of randomized clinical trials showed that in singleton pregnancies with short cervix, prophylactic use of the pessary did not reduce the rate of spontaneous preterm delivery or improve perinatal outcome. The evidence supports the use of vaginal progesterone in singleton pregnancies with short cervix, while cervical cerclage seems to be beneficial only in the subgroup of women with both prior SPTB and TVU CL ≤25mm. Interestingly, only 235 singletons without prior SPTB,7 and 504 singletons gestations with prior SPTB,6 have been included in randomized studies on cerclage for TVU CL ≤25mm. A meta-analysis of four trials showed that cervical cerclage did not prevent SPTB in women with short TVU CL and without prior preterm birth.7 However, even if the statistical significance were not reached, they found a reduction in SPTB \<35 weeks by 16% in singletons with short TVU CL and without prior SPTB (20.6% vs 31.2%; relative risk (RR) 0.84, 95% confidence interval (CI) 0.60 to 1.17) and by 24% in singletons without risk factors for SPTB (25.6% vs 33.3%; RR 0.76, 95% CI 0.52 to 1.15). Therefore, the aim of this study is to evaluate the efficacy of cervical cerclage in prevention of SPTB in singleton pregnancies with short TVU CL in second trimester, without prior SPTB.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Apr 2016
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 8, 2016
CompletedFirst Posted
Study publicly available on registry
April 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2019
CompletedApril 21, 2016
April 1, 2016
2 years
April 8, 2016
April 18, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Spontaneous preterm birth (SPTB)
Less than 35 weeks gestation
Secondary Outcomes (10)
Spontaneous preterm birth (SPTB)
Less than 37,34,32,28 and 24 weeks gestation
Gestational age at delivery
Delivery (at birth)
Latency
Delivery (at birth)
chorioamnionitis
Delivery (at birth)
Birth weight
Delivery (at birth)
- +5 more secondary outcomes
Study Arms (2)
Cervical cerclage
EXPERIMENTALAfter the woman is placed in the dorsal lithotomy position and the bladder is emptied with a urinary catheter to reduce the chance of bladder injury, surgical preparation with Betadine will be performed. Breisky retractors and Sims retractors will be used to exposure the entire cervix. Sponge ring forceps will be used to optimized visualization of the cervix and provide the necessary countertraction at the suture entry and exit sites. McDonald technique will be performed placing 4-6 bites circumferentially around the cervix. Only one stitch will be used. The suture will be places as high as feasible
No intervention
NO INTERVENTIONBed rest will be not recommended.
Interventions
Eligibility Criteria
You may qualify if:
- ages
- Singleton pregnancy
- Cervical length \<=25mm between 18(0) and 23(6) weeks
You may not qualify if:
- Multiple pregnancy
- Prior spontaneous preterm birth or second trimester losses between 16(0) and 36(6) weeks
- Cerclage in situ
- Painful regular uterine contraction and/or preterm labor
- Ruptured membranes
- Major fetal defects
- Active vaginal bleeding
- Placenda previa and/or accreta
- Cervical dilation \>1.5 cm and/or visible membranes by pelvic exam
- Suspicion of chorioamnionitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gabriele Saccone
Napoli, 80129, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
April 8, 2016
First Posted
April 21, 2016
Study Start
April 1, 2016
Primary Completion
April 1, 2018
Study Completion
April 1, 2019
Last Updated
April 21, 2016
Record last verified: 2016-04